A drug to treat hemophilia was polluted with hepatitis viruses and HIV

An excerpt from Doctor Guilt?

by Everett Winslow Lovrien, MD

This is the story of a boy who had hemophilia, a bleeding disorder that resulted in pain, disability and death before adulthood. A new medicine was developed which brought an end to suffering and increased longevity in persons with hemophilia.  The effect of the new medicine was like magic. It was a remarkable revolutionary advancement …

Read more…

A drug to treat hemophilia was polluted with hepatitis viruses and HIV

Controversy about NSAIDs and heart health

by Marianna Rakovitsky, RPh

Recently there has been a lot of controversy  about the use of NSAIDs and heart health.

NSAIDs are medications for pain and inflammation. Many of them are sold over the counter and they are used by millions of people for various aches and pains as well as for more serious chronic conditions such as arthritis. Aspirin is technically an NSAID, but its effects …

Read more…

Controversy about NSAIDs and heart health

HIV sufferers benefit from the FDA’s unapproved drugs initiative

by Gary Puckrein, PhD

Unapproved drugs have never been tested by the Food and Drugs Administration for safety and efficacy. Prescribed by the million every year in the United States, these products pose a potential danger to all patients, but HIV/AIDS patients who suffer weakened immune systems are at an even higher risk as they are more vulnerable to injury due to their disease.

That’s why we …

Read more…

HIV sufferers benefit from the FDA’s unapproved drugs initiative

How academic physicians turn into drug company shills

An excerpt from White Coat, Black Hat.

by Carl Elliott

These days many thought leaders find themselves on shaky ground. The past few years have not been good for business. Some of the most prominent thought leaders have been exposed and censured by Grassley. Others have seen public opinion turning against them and gone underground. As more states institute Sunshine laws, anyone considering an industry …

Read more…

How academic physicians turn into drug company shills

ADVERTISEMENT

Are opioids any less safe or effective in non cancer patients?

by Drew Rosielle, MD

Recently, the New York Times reported of the movement in Washington State to officially do something about prescription opioid abuse, coming on the heels of course of the FDA rejecting the current risk evaluation and mitigation strategy plan as, essentially, not going far enough.

The article basically discusses the discussion in Washington about what to do; no formal new plans have been …

Read more…

Are opioids any less safe or effective in non cancer patients?

54
pages